QUOTED. 10 June 2019. Cisco Vicenty.
Executive Summary
The FDA wants to spur medical device innovation and production in the US with its new "Bring MedTech Manufacturing Home" initiative – and the agency already has a leg up on that goal with its ongoing Case for Quality Voluntary Improvement Program (CFQ VIP) that measures device-makers' manufacturing maturity and quality. See what the FDA's Cisco Vicenty said about it here.
"The Case for Quality VIP initiative is part of what's under that [Bring MedTech Manufacturing Home] umbrella for establishing a third-party mechanism – one that will allow us to use a lot of what we've already put into practice, and make that a sustained and operational operation and mode for future activities." – Cisco Vicenty, Case for Quality program manager, US FDA
- Find out more: Make America Manufacture Again? FDA Incentivizing 'Smart Manufacturing Solutions' To Shift Device-Making To US
Click here for a free trial of Medtech Insight